Literature DB >> 28379410

Diagnostic performance of retinal digital photography for diabetic retinopathy screening in primary care.

Ana P O Rosses1,2, Ângela J Ben1,3,4, Camila Furtado de Souza3,5, Adriana Skortika6, Aline Lutz de Araújo3, Gabriela de Carvalho1, Franciele Locatelli1, Cristina R Neumann1,5.   

Abstract

Introduction: We must study alternatives to structure an effective diabetic retinopathy screening program for Brazilian public health system.
Objectives: Evaluate the diagnostic performance of retinal digital photography for diabetic retinopathy screening in primary care, accuracy of the family physician in diabetic retinopathy identification compared to the ophthalmologist, and the need for dilation. Methodology: In a primary care service were performed retinal photographs with non-mydriatic Retinal Camera in 219 type 2 diabetic patients with and without medication mydriasis. We evaluated the performance of the diagnostic of the photos graded by three family physicians with training compared to two ophthalmologists (gold standard), and explore related factors with the need for mydriasis pharmacologically.
Results: The prevalence of diabetic retinopathy and proliferative diabetic retinopathy was 19.2% and 1.5%, respectively. The sensitivity of family physicians to evaluate diabetic retinopathy averaged 82.9% (66.7-94.8%); specificity, 92% (90.2-93.3%); the accuracy, 90.3% (88.2-93%) and positive predictive value, 71.2% (68-75.5%). The agreement calculated using the kappa adjusted coefficient was from 0.74 to 0.8 for retinopathy and 0.88 to 0.92 for macular edema. Without drug mydriasis the photos were unreadable by 14.8%, when using mydriatic collyrium this number decreased to 8.7% (McNemar test, P < 0.005). Patients with more than 65 years old has more readability after drug mydriasis (McNemar test, P = 0.011).
Conclusion: Trained family physician reached a good performance for evaluation of retinography for diabetic retinopathy. There was improvement in readability with pupil dilation in older patients.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Diabetes / insulin resistance; family health; ophthalmology / visual impairment; prevention; screening

Mesh:

Substances:

Year:  2017        PMID: 28379410     DOI: 10.1093/fampra/cmx020

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  4 in total

1.  Knowledge and practices of primary care physicians on the current referral system of diabetic retinopathy in Islamabad and Rawal-Pindi, Pakistan.

Authors:  Muhammad Shakaib Anwar; Baila Shakaib; Waseem Akhtar; Erum Yusufzai; Maham Zehra; Hajira Munawar; Kinza Azhar
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

2.  Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study.

Authors:  Divya Parthasarathy Rao; Manavi D Sindal; Sabyasachi Sengupta; Prabu Baskaran; Rengaraj Venkatesh; Anand Sivaraman; Florian M Savoy
Journal:  Clin Ophthalmol       Date:  2022-08-17

3.  Non-Mydriatic Fundus Retinography in Screening for Diabetic Retinopathy: Agreement Between Family Physicians, General Ophthalmologists, and a Retinal Specialist.

Authors:  Leonardo Provetti Cunha; Evelyn Alvernaz Figueiredo; Henrique Pereira Araújo; Luciana Virgínia Ferreira Costa-Cunha; Carolina Ferreira Costa; José de Melo Costa Neto; Aline Mota Freitas Matos; Marise Machado de Oliveira; Marcus Gomes Bastos; Mário Luiz Ribeiro Monteiro
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-18       Impact factor: 5.555

4.  The use of telemedicine to support Brazilian primary care physicians in managing eye conditions: The TeleOftalmo Project.

Authors:  Aline Lutz de Araujo; Taís de Campos Moreira; Dimitris Rucks Varvaki Rados; Paula Blasco Gross; Cynthia Goulart Molina-Bastos; Natan Katz; Lisiane Hauser; Rodolfo Souza da Silva; Sabrina Dalbosco Gadenz; Rafael Gustavo Dal Moro; Felipe Cezar Cabral; Lucas Matturro; Cássia Garcia Moraes Pagano; Amanda Gomes Faria; Maicon Falavigna; Ana Célia da Silva Siqueira; Paulo Schor; Marcelo Rodrigues Gonçalves; Roberto Nunes Umpierre; Erno Harzheim
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.